| Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine |
57 |
| Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM |
38 |
| Use of Metabolomics in Improving Assessment of Dietary Intake |
34 |
| Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research: A White Paper, Community Perspective (for Precision Medicine and Pharmacometabolomics Task Group-The Metabolomics Society Initiative) |
29 |
| The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union |
29 |
| Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility |
29 |
| State of the Science in Dried Blood Spots |
27 |
| Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis |
27 |
| Obesity and Cancer: Evidence, Impact, and Future Directions |
25 |
| Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA |
23 |
| Comparison of Generic Fluorescent Markers for Detection of Extracellular Vesicles by Flow Cytometry |
22 |
| Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-beta 1-42 Analysis Results |
20 |
| Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites |
20 |
| Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort |
19 |
| Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients |
18 |
| Food Addiction, High-Glycemic-Index Carbohydrates, and Obesity |
18 |
| The Impact of Obesity on Medical Care Costs and Labor Market Outcomes in the US |
18 |
| The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation |
18 |
| Differences between Men and Women in Mortality and the Health Dimensions of the Morbidity Process |
18 |
| Current and Emerging Trends in Point-of-Care Technology and Strategies for Clinical Validation and Implementation |
17 |
| In Situ Detection and Quantification of AR-V AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells |
17 |
| Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk |
16 |
| IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples |
16 |
| Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction |
15 |
| Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing |
15 |
| Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients |
14 |
| Noninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR |
14 |
| Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma |
13 |
| Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction |
13 |
| The EuBIVAS: Within- and Between-Subject Biological Variation Data for Electrolytes, Lipids, Urea, Uric Acid, Total Protein, Total Bilirubin, Direct Bilirubin, and Glucose |
13 |
| Performance of the MasSpec Pen for Rapid Diagnosis of Ovarian Cancer |
13 |
| Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR |
12 |
| Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing |
12 |
| Role of Physical Activity and Exercise in Treating Patients with Overweight and Obesity |
12 |
| Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism |
12 |
| IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design |
12 |
| Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids |
12 |
| Low-Grade Inflammation in the Association between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population |
12 |
| Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study |
12 |
| Genetic Evidence That Carbohydrate-Stimulated Insulin Secretion Leads to Obesity |
11 |
| Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products |
11 |
| RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients |
11 |
| A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic Effect |
11 |
| Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study |
11 |
| Resolution of Spurious Immunonephelometric IgG Subclass Measurement Discrepancies by LC-MS/MS |
11 |
| Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic? |
11 |
| Circular RNAs in Urine of Kidney Transplant Patients with Acute T Cell-Mediated Allograft Rejection |
11 |
| Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis |
11 |
| Patient-Based Real-Time Quality Control: Review and Recommendations |
11 |
| Low- and High-renin Heart Failure Phenotypes with Clinical Implications |
11 |
